Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia
NCT06466369 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 306
Last updated 2024-08-23
Summary
The aim of the present study is to evaluate the efficacy and safety of once daily administration PDE5 inhibitors, tadalafil for 3 months as anti-inflammatory, antiproliferative and relaxant effects in ED with BPH patients.
Conditions
- BPH With Other Lower Urinary Tract Symptoms
Interventions
- DRUG
-
Tadalafil
tadalafil 2.5 mg, 5 mg
Sponsors & Collaborators
-
Al-Azhar University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-15
- Primary Completion
- 2024-07-01
- Completion
- 2024-08-01
Countries
- Egypt
Study Locations
More Related Trials
-
Safety and Efficacy of Tadalafil vs. Tadalafil With Sildosin in the Management of Moderately and Severely Symptomatic Patients of Prostatic Hyperplasia
NCT04577040 ·Status: UNKNOWN
-
Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients with Prostate Volumes ≤ 40 Ml: a Prospective Comparative Study
NCT06809205 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Endoscopic Enucleation of Prostate
NCT05955001 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB
NCT05494567 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms
NCT02252367 ·Status: COMPLETED ·Phase: PHASE4
-
Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
NCT06491108 ·Status: RECRUITING ·Phase: PHASE3
-
Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men
NCT00540124 ·Status: COMPLETED ·Phase: PHASE2
-
Tadalafil Daily Used Post Turp
NCT06788704 ·Status: COMPLETED
-
A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).
NCT02431754 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
NCT01139762 ·Status: COMPLETED ·Phase: PHASE3
-
Benign Prostatic Hyperplasia in Taiwan
NCT00941343 ·Status: COMPLETED ·Phase: NA
-
A Study of Tadalafil After Radical Prostatectomy
NCT01026818 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study
NCT05818670 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients
NCT03246880 ·Status: COMPLETED ·Phase: PHASE3
-
Adding Desmopressin to Tamsulosin for Treatment of BPH
NCT05945420 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
NCT04947631 ·Status: COMPLETED ·Phase: PHASE3
-
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
NCT00701779 ·Status: COMPLETED ·Phase: PHASE4
-
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
NCT03297398 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction
NCT01967251 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
NCT05558007 ·Status: RECRUITING ·Phase: PHASE2
-
Intermittent vs Daily Tamsulosin for LUTS/BPH
NCT07308002 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction
NCT02862483 ·Status: UNKNOWN ·Phase: PHASE3
-
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
NCT05834270 ·Status: COMPLETED ·Phase: NA
-
The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score
NCT00540891 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects
NCT02839122 ·Status: COMPLETED ·Phase: PHASE1